Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net interest income | -46.11%48.07M | -45.68%31.3M | -51.96%12.36M | 9.60%111.36M | 23.96%89.19M | 36.36%57.63M | 25.87%25.73M | 10.17%101.6M | -3.13%71.95M | -14.13%42.26M |
| -Interest income | -46.40%48.08M | -46.09%31.32M | -52.37%12.37M | 8.79%111.89M | 23.23%89.71M | 35.54%58.09M | 25.72%25.98M | 10.70%102.85M | -2.64%72.8M | -13.56%42.86M |
| -Interest expense | 97.33%-13.96K | 97.01%-13.96K | 94.38%-13.96K | 57.07%-535.69K | 38.52%-522.37K | 22.05%-466.32K | 4.87%-248.2K | -83.12%-1.25M | -69.16%-849.6K | -62.43%-598.21K |
| Net service income | -10.76%118.39M | -18.08%75.22M | -2.74%35.55M | -11.73%179.32M | -11.42%132.67M | 3.82%91.82M | -19.99%36.55M | -17.37%203.14M | -20.30%149.76M | -39.40%88.45M |
| Special items of operating revenue | -83.27%295.33M | -75.43%216.01M | 409.68%594.77M | 57.78%2.59B | 103.11%1.77B | 12.66%879.03M | 17.67%116.7M | 37.72%1.64B | 22.38%869.31M | 39.44%780.28M |
| Operating revenue | -76.77%461.78M | -68.64%322.53M | 259.09%642.68M | 47.99%2.88B | 82.17%1.99B | 12.90%1.03B | 8.27%178.98M | 27.20%1.94B | 12.19%1.09B | 20.70%910.99M |
| Operating expenses - before deducting impairment | 76.59%-460.72M | 67.61%-328.41M | -228.14%-641.34M | -46.70%-2.84B | -80.63%-1.97B | -12.55%-1.01B | -23.85%-195.45M | -28.11%-1.94B | -16.46%-1.09B | -27.05%-900.82M |
| Operating profit before deducting impairment | -94.46%1.06M | -140.16%-5.88M | 108.17%1.34M | 428.90%34.64M | 1,342.03%19.22M | 44.02%14.64M | -319.87%-16.47M | -58.99%6.55M | -96.38%1.33M | -77.78%10.16M |
| Operating profit after deducting impairment | -94.46%1.06M | -140.16%-5.88M | 108.17%1.34M | 428.90%34.64M | 1,342.03%19.22M | 44.02%14.64M | -319.87%-16.47M | -58.99%6.55M | -96.38%1.33M | -77.78%10.16M |
| -Special items of operating expenditure | ---- | 16.47%-3.28M | 17.00%-1.54M | 10.11%-7.52M | ---- | -17.39%-3.93M | ---1.86M | 13.13%-8.37M | ---- | ---3.35M |
| Operating profit | -94.46%1.06M | -140.16%-5.88M | 108.17%1.34M | 428.90%34.64M | 1,342.03%19.22M | 44.02%14.64M | -319.87%-16.47M | -58.99%6.55M | -96.38%1.33M | -77.78%10.16M |
| Adjustment items of earning before tax | -83.33%422.53K | -89.55%207.02K | 447.48%159.18K | -7.04%3.65M | 430.06%2.54M | 1,883.61%1.98M | -117.85%-45.81K | 6,167.49%3.92M | 4.93%478.33K | -67.24%99.84K |
| Earning before tax | -93.16%1.49M | -134.12%-5.67M | 109.11%1.5M | 265.63%38.29M | 1,101.19%21.76M | 61.92%16.62M | -313.18%-16.52M | -34.17%10.47M | -95.14%1.81M | -77.71%10.26M |
| Tax | 111.28%602.22K | 154.11%2.06M | -109.26%-300.94K | -215.71%-8.46M | -492.72%-5.34M | -21.70%-3.82M | 269.45%3.25M | 23.96%-2.68M | 89.33%-900.39K | 70.91%-3.14M |
| After-tax profit from continuing operations | -87.27%2.09M | -128.17%-3.61M | 109.07%1.2M | 282.80%29.83M | 1,702.66%16.42M | 79.61%12.8M | -327.56%-13.27M | -37.07%7.79M | -96.84%910.88K | -79.78%7.13M |
| Earning After tax | -87.27%2.09M | -128.17%-3.61M | 109.07%1.2M | 282.80%29.83M | 1,702.66%16.42M | 79.61%12.8M | -327.56%-13.27M | -37.07%7.79M | -96.84%910.88K | -79.78%7.13M |
| Profits attributable to shareholders | -87.27%2.09M | -128.17%-3.61M | 109.07%1.2M | 282.80%29.83M | 1,702.66%16.42M | 79.61%12.8M | -327.56%-13.27M | -37.07%7.79M | -96.84%910.88K | -79.78%7.13M |
| Basic earnings per share | -87.12%0.0021 | -128.35%-0.0036 | 109.09%0.0012 | 284.42%0.0296 | 1,711.11%0.0163 | 78.87%0.0127 | -327.59%-0.0132 | -41.67%0.0077 | -97.13%0.0009 | -81.75%0.0071 |
| Diluted earnings per share | -87.12%0.0021 | -128.35%-0.0036 | 109.09%0.0012 | 284.42%0.0296 | 1,711.11%0.0163 | 78.87%0.0127 | -327.59%-0.0132 | -41.67%0.0077 | -97.13%0.0009 | -81.75%0.0071 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Xinyong Zhonghe Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.